Patron Exim
PATRONEXIMLTD NSE
Patron Exim
ChemicalsNSE: PATRONEXIMLTD BSE: PATRON Commodity Chemicals
Key Fundamentals
SMECommodity ChemicalsChemicalsMarket Cap
₹4.50 Cr
Volatility
Low Risk
P/E Ratio
-4.1
EBITDA
₹-1.17 Cr
Return on Equity
0.18%
Debt to Equity
0.05
Book Value
₹16.45
EPS
₹0.6
52W High
₹9.92
52W Low
₹1.42
Tapetide Score
Data-driven rating, 0–100. How it works →
Key Insights
Strengths
3- Company is almost debt free.
- Stock is trading at 0.12 times its book value
- Debtor days have improved from 239 to 63.3 days.
Weaknesses
4- Company has low interest coverage ratio.
- Promoter holding is low: 20.0%
- Company has a low return on equity of -0.30% over last 3 years.
- Promoter holding has decreased over last 3 years: -51.2%
Growth Rate
Revenue Growth
-1.98% lower than
3Y
Net Income Growth
—
Cash Flow Change
96.15% lower than
3Y
ROE
-89.41% lower than
3Y
ROCE
-88.26% higher than
3Y
EBITDA Margin (Avg.)
—
Quarterly Results
| Particulars | Mar 2022 | Sep 2022 | Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 3.88 | 9.46 | 3.5 | 1.26 | 5.32 | 0 | 24.36 | 23.72 | 0.49 |
| Expenses | 3.41 | 8.87 | 8.07 | 4.14 | 5.18 | 0.48 | 24.09 | 23.74 | 1.63 |
| Operating Profit | 0.47 | 0.59 | -4.57 | -2.88 | 0.14 | -0.48 | 0.27 | -0.02 | -1.14 |
| OPM % | 12.11% | 6.24% | -130.57% | -228.57% | 2.63% | — | 1.11% | -0.08% | -232.65% |
| Other Income | 1.14 | 0.25 | 5.69 | 2.98 | 0.66 | 0.23 | 0.09 | 0.04 | 0.04 |
| Interest | 0.11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | 1.49 | 0.84 | 1.12 | 0.1 | 0.8 | -0.25 | 0.36 | 0.02 | -1.1 |
| Tax % | 28.86% | 28.57% | 28.57% | 30% | 26.25% | 12% | 11.11% | 50% | 0% |
| Net Profit | 1.07 | 0.59 | 0.79 | 0.07 | 0.59 | -0.28 | 0.32 | 0.01 | -1.1 |
| EPS in Rs | — | 0.39 | 0.34 | 0.03 | 0.25 | -0.12 | 0.14 | 0 | -0.47 |
Profit & Loss
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Sales | 3.88 | 12.95 | 6.58 | 24.36 | 24.21 |
| Expenses | 3.41 | 16.92 | 9.33 | 24.57 | 25.38 |
| Operating Profit | 0.47 | -3.97 | -2.75 | -0.21 | -1.17 |
| OPM % | 12.11% | -30.66% | -41.79% | -0.86% | -4.83% |
| Other Income | 1.14 | 5.93 | 3.65 | 0.32 | 0.09 |
| Interest | 0.19 | 0 | 0 | 0 | 0 |
| Depreciation | 0.01 | 0.01 | 0 | 0 | 0 |
| PBT | 1.41 | 1.95 | 0.9 | 0.11 | -1.08 |
| Tax % | 30.5% | 29.23% | 25.56% | 36.36% | 0.93% |
| Net Profit | 0.99 | 1.38 | 0.67 | 0.07 | -1.09 |
| EPS in Rs | — | 0.6 | 0.29 | 0.03 | -0.47 |
| Div. Payout % | 0% | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Equity Capital | 5.34 | 23.18 | 23.18 | 23.18 | 23.18 |
| Reserves | 0 | 15.29 | 15.96 | 16.03 | 14.94 |
| Borrowings | 0 | 0.03 | 0.26 | 0.23 | 2.09 |
| Other Liabilities | 5.62 | -0.02 | 5.93 | 4.81 | 8.49 |
| Total Liabilities | 10.96 | 38.48 | 45.33 | 44.25 | 48.7 |
| Fixed Assets | 0.01 | 0.01 | 0.01 | 0.01 | 0.04 |
| CWIP | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 8.67 | 8.67 | 8.76 | 8.84 |
| Other Assets | 10.95 | 29.8 | 36.65 | 35.48 | 39.82 |
| Total Assets | 10.96 | 38.48 | 45.33 | 44.25 | 48.7 |
Cash Flow
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Operating | 0.76 | -22.81 | -0.26 | -0.01 | -2.01 |
| Investing | 0 | -8.68 | 0 | 0 | -0.04 |
| Financing | -0.76 | 31.78 | 0.23 | -0.03 | 1.86 |
| Net Cash Flow | 0 | 0.29 | -0.04 | -0.04 | -0.19 |
| Free Cash Flow | 0.76 | -22.82 | -0.26 | -0.01 | -2.05 |
| CFO/OP | 253 | 560 | 1 | -14 | 171 |
Ratios
| Particulars | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Debtor Days | 710 | 394 | 562 | 91.55 | 63.32 |
| Inventory Days | 337 | 89.82 | 309 | 42.61 | 14.84 |
| Days Payable | 537 | -23.95 | 625 | 61.07 | 104 |
| Cash Conversion Cycle | 510 | 508 | 245 | 73.09 | -26.15 |
| Working Capital Days | 500 | 831 | 1,675 | 453 | 573 |
| ROCE % | — | 8.9% | 2.31% | 0.28% | -2.71% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Patron Exim insights
48 extracted metrics + investor summaries across FY21–FY26.
Documents
1
Board Meeting Intimation for The Declaration Of Audited Financial Results For The Half-Year And Year Ended 31St March, 2026
13h - Board meeting postponed from May 11 to May 29, 2026 for FY26 audited results approval. 13h - Board meeting postponed from May 11 to May 29, 2026 for FY26 audited results approval.
2
Board Meeting Intimation for Declaration Of Audited Standalone Financial Results Of The Company For The Half Year And Year Ended On 31St March, 2026
6 May - Board to meet on 11 May 2026 to approve audited FY2026 financial results. 6 May - Board to meet on 11 May 2026 to approve audited FY2026 financial results.
3
Clarification On Price Movement Of Shares
20 Apr - Patron Exim says share price movement is market-driven; no material event exists. 20 Apr - Patron Exim says share price movement is market-driven; no material event exists.
4
Clarification sought from Patron Exim Ltd
20 Apr - Exchange has sought clarification from Patron Exim Ltd on April 20, 2026, with reference to Movement in Price. 20 Apr - Exchange has sought clarification from Patron Exim Ltd on April 20, 2026, with reference to Movement in Price.
5
Clarification On Price Movement Of Shares
12h - Patron Exim says share price movement is market-driven; no material event exists. 12h - Patron Exim says share price movement is market-driven; no material event exists.
Frequently Asked Questions about Patron Exim
What does Patron Exim Ltd do?
Incorporated in 1992, Patron Exim Ltd is in the business of trading pharma products and commission agent in pharma products, etc.[1]
Where is Patron Exim Ltd (543798) listed?
Patron Exim Ltd trades as PATRONEXIMLTD on the NSE and under code PATRON on the BSE.
Which sector does Patron Exim Ltd belong to?
Patron Exim Ltd is classified under the Chemicals sector, in the Commodity Chemicals industry.
What is the market capitalisation of Patron Exim Ltd?
Patron Exim Ltd has a market capitalisation of ₹4.5 Cr, which places it in the Small Cap band.
What is the PE ratio of Patron Exim Ltd?
Patron Exim Ltd trades at a PE ratio of -4.10, on earnings per share of ₹0.6, against a book value of ₹16.45 per share.
What is the 52-week high and low of Patron Exim Ltd?
Over the last 52 weeks Patron Exim Ltd has traded between ₹1.42 and ₹9.92.
What is the Return on Equity (ROE) of Patron Exim Ltd?
Patron Exim Ltd reported a return on equity of 0.18%. Its debt-to-equity ratio is 0.05.
Company Information
Incorporated in 1992, Patron Exim Ltd is in the business of trading pharma products and commission agent in pharma products, etc.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/543798.md for Patron Exim Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live,
structured queries instead of documents, use our MCP server.